The Potential for Treatment Shortening With Higher Rifampicin Doses : Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

Autor: Lilian T. Minja, Rob E. Aarnoutse, Ulrika S. H. Simonsson, Rodney Dawson, Lindsey H.M. te Brake, Andreas H. Diacon, Sarah Konsten, Ian Sanne, Martin J. Boeree, Gibson S. Kibiki, Norbert Heinrich, Nyanda E Ntingiya, Patrick P. J. Phillips, Michael Hoelscher, Elin M. Svensson, Gavin J. Churchyard, Stephen H. Gillespie, Robin J. Svensson

Publikováno v: Clinical Infectious Diseases, 67, 1, pp. 34-41
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 67, iss 1
Clinical Infectious Diseases, 67, 34-41

This work was supported by the European and Developing Countries Clinical Trials partnership (grants IP.2007.32011.011, IP.2007.32011.012, and IP.2007.32011.013) and the German Ministry for Education and Research (grant 01KA0901). The original study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b287586e2a950ea514884f18a25399fe
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-361283